Inflammatory Bowel Syndrome
Although large-scale studies on the use of hyperbaric oxygen therapy for inflammatory bowel disease are still in their early stages, initial results are promising. Hyperbaric therapy has shown potential in reducing pain, inflammation, and symptoms, offering a hopeful new treatment option for patients.
Traditional treatments, which rely on corticosteroids, anti-inflammatories, and immunomodulators, often come with serious long-term side effects. In contrast, hyperbaric therapy targets both tissue hypoxia and inflammation with minimal side effects, making it a compelling alternative.
Click the links below to read Case Studies
SOURCES:
BMJ Open Gastroenterology 2016;3:e000082. doi: 10.1136/bmjgast-2016-000082
Systematic review: the safety and efficacy of hyperbaric oxygen therapy for inflammatory bowel disease First published: 16 April 2014; https://doi.org/10.1111/apt.12753